首页> 中文期刊> 《中国糖尿病杂志》 >脂联素对2型糖尿病患者内皮祖细胞增殖及迁移活性影响的体外研究

脂联素对2型糖尿病患者内皮祖细胞增殖及迁移活性影响的体外研究

         

摘要

Objective To study the effect and possible mechanism of adiponectin on the proliferation and migration of endotheiial progenitor cells (EPCs) in vitro in T2DM patients. Methods Mononuclear cells from T2DM patients were isolated by Ficoll density gradient centrifugation and then cultured. The EPCs were identified with the FITC-UEA-Ⅰ and Dil-acLDL stainings and divided into the control group, adiponectin (10ug/M1) group, PI3K-inhibitor (Ly294002) group, and ERK-inhibitor (PD98059) group. The proliferation of EPCs of all groups was observed with MTT assay, the migratory activity was calculated with colony forming units (CFU), the changes in migratory activity was analyzed with transwell assay, and the expressions of phosphorylated Akt and eNOS were measured by Western blot analysis. Results Compared with the control group, the proliferative and migratory activities of EPCs were significantly enhanced after treatment in the adiponectin group, while in the PI3K-inhibitor group, the effect of adiponectin on the improvement of proliferative and migratory activities of EPCs was inhibited. The Western blot a-nalysis showed that the expressions of phosphorylated Akt and eNOS were significantly increased in the adiponectin group in comparing with the control group, but the PI3K-inhibitor could effectively inhibit the effect of adiponectin on phosphorylated Akt Conclusion Adiponectin improves the proliferative and migratory activities of EPCs in T2DM patients by the activation of PI3K/Akt/eNOS signal pathway.%目的 研究APN对糖尿病患者内皮祖细胞(EPCs)增殖、迁移能力的影响并探讨其可能机制. 方法 利用密度梯度离心法分离、培养T2DM患者外周血单个核细胞,经FITC-UEA-I和Dil-acLDL双染色鉴定为正在分化的EPCs.将分离、培养的EPCs分为对照(Con)组、APN组(10μg/ml)、PI3K抑制剂(Ly294002)干预组及ERK抑制剂(PD98059)干预组.采用MTT比色法、细胞集落形成单位计数等方法观察各组EPCs增殖能力的变化情况,应用Transwell小室法分析EPCs迁移能力的变化,同时本研究采用免疫蛋白印迹法观察APN处理EPCs后磷酸化Akt,以及磷酸化eNOS的表达变化情况,以探讨其可能机制. 结果 与Con组相比,APN组EPCs的增殖能力显著提高,而在PI3K抑制剂干预组,APN对EPCs增殖、迁移活性的改善作用受到抑制.另外,免疫蛋白印迹法的结果显示:相比于Con组,APN组p-Akt、p-eNOS的表达水平明显增高,而PI3K抑制剂干预后能够有效地抑制APN促Akt磷酸化的效应. 结论 APN促进糖尿病患者EPCs增殖、迁移等功能,其主要机制可能与PI3K/Akt/eNOS的信号通路激活有关.

著录项

  • 来源
    《中国糖尿病杂志》 |2012年第9期|697-700|共4页
  • 作者单位

    442000 十堰,湖北医药学院附属太和医院心内科;

    湖北省郧县人民医院心内科;

    442000 十堰,湖北医药学院附属太和医院心内科;

    442000 十堰,湖北医药学院附属太和医院心内科;

    442000 十堰,湖北医药学院附属太和医院心内科;

    442000 十堰,湖北医药学院附属太和医院心内科;

    442000 十堰,湖北医药学院附属太和医院心内科;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

    APN; 内皮祖细胞; 糖尿病,2型;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号